All In MedTech

Device Trial Radar · NCT05163392

A Silver Lining in the VAD Sky

A Silver Lining in the VAD Sky: Impact of Silver Dressing on LVAD Associated Driveline Infection

Last checked: Nov 19, 2026Latest source record: Feb 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

25

Actual

Start

Feb 1, 2022

Primary completion

Dec 1, 2024

Study completion Jan 26, 2026

Sponsor

Lead sponsor
University of California, San FranciscoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
International Consortium of Circulatory Assist Clinicians
First posted
Dec 20, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The investigators propose to conduct a prospective randomized trail (RCT) of a driveline management protocol. The study will be initiated at UCSF from January 1st 2022 to December 31st 2022 as a pilot to be extended to other sites with the ultimate goal to develop a multi-center RCT. The driveline dressing protocol studied will include a silver-based dressing barrier as well as a dressing change protocol and material designed to reduce the risk of driveline dressing induced dermatitis and allergies. Assessment will include DLI rates, DLI speciation, dermatitis rate, comfort, ease of use, compliance and cost

Conditions

  • LVAD (Left Ventricular Assist Device) Driveline Infection

Interventions

  • SilverlonDevice

    SIlver-plated biopatch

  • ControlDevice

    Tegaderm without biopatch

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Driveline Infection RateTime frame: 2 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UCSF Parnassus

    San Francisco, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.